Epidemiology and burden of multidrug-resistant bacterial infection in a developing country

eLife

Volumn 5, Issue September, 2016, Pages

  Lim, Cherry ^a   Takahashi, Emi ^a   Hongsuwan, Maliwan ^a   Wuthiekanun, Vanaporn ^a   Thamlikitkul, Visanu ^b   Hinjoy, Soawapak ^c   Day, Nicholas P J ^a,d   Peacock, Sharon J ^a,e,f   Limmathurotsakul, Direk ^a,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE;

ACINETOBACTER; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MIDDLE INCOME COUNTRY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; THAILAND; BACTERIUM; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; CROSS INFECTION; DEVELOPING COUNTRY; DRUG EFFECTS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SURVIVAL ANALYSIS;

BACTEREMIA; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; CROSS INFECTION; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THAILAND;

EID: 84988527741     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18082     Document Type: Article

References (30)

1. Ansari S, Nepal HP, Gautam R, Shrestha S, Neopane P, Gurung G, Chapagain ML. 2015. Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. Antimicrobial Resistance and Infection Control 4:15. doi: 10.1186/s13756-015-0059-2
2. Benichou J. 2001. A review of adjusted estimators of attributable risk. Statistical Methods in Medical Research 10:195-216. doi: 10.1191/096228001680195157
3. Bursac Z, Gauss CH, Williams DK, Hosmer DW. 2008. Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine 3:17. doi: 10.1186/1751-0473-3-17
4. Center for Disease Controls and Prevention, U.S. Department of Health and Human Services. 2013. Antibiotic resistance threats in the United States, 2013. (accessed February 4, 2016) http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
5. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, Camacho-Cosavalente LA, Castillo-Bravo LI. 2008. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Revista Panamericana De Salud Pública 24:16-24. doi: 10.1590/S1020-49892008000700002
6. European Centre for Disease Prevention and Control and European Medicines Agency. 2009. ECDC/EMEA joint technical report the bacterial challenge: Time to react 2009. (accessed January 13, 2016) http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
7. Falagas ME, Rafailidis PI. 2007. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Critical Care 11:134. doi: 10.1186/cc5911
8. Fishbain J, Peleg AY. 2010. Treatment of Acinetobacter infections. Clinical Infectious Diseases 51:79-84. doi: 10.1086/653120
9. Greenland S, Robins JM. 1988. Conceptual problems in the definition and interpretation of attributable fractions. American Journal of Epidemiology 128:1185-1197.
10. Hongsuwan M, Srisamang P, Kanoksil M, Luangasanatip N, Jatapai A, Day NP, Peacock SJ, Cooper BS, Limmathurotsakul D. 2014. Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: a multicenter surveillance study. PLoS ONE 9:e109324. doi: 10.1371/journal.pone.0109324
11. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. 2013. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS ONE 8:e54714. doi: 10.1371/annotation/e199ebcc-0bc1-4be1-ad91-ad2a8c0c9382
12. Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. 2010. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatrics 10:39. doi: 10.1186/1471-2431-10-39
13. Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, Ryu SY, Heo ST, Jung DS, Rhee JY, Shin SY, Ko KS, Peck KR, Lee NY. 2007. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. Journal of Antimicrobial Chemotherapy 59:525-530. doi: 10.1093/jac/dkl499
14. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, et al. 2013. Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases 13: 1057-1098. doi: 10.1016/S1473-3099(13)70318-9
15. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 18:268-281. doi: 10.1111/j.1469-0691.2011.03570.x
16. Martone WJ, Jarvis WR, Edwards JR, Culver DH, Haley RW. 1998. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett J. V, Brachman P. S (Eds). Hospital Infections.. 4th ed Philadelphia, PA, USA: Lippincott-Raven. p 461-476
17. Moine P, Timsit JF, De Lassence A, Troché G, Fosse JP, Alberti C, Cohen Y., OUTCOMEREA study group. 2002. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Medicine 28:154-163. doi: 10.1007/s00134-001-1172-7
18. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, Rojas C, Osorio L, Linares C, Valderrama A, Mercado PG, Bernate PH, Vergara GR, Pertuz AM, Mojica BE, Navarrete MP, Romero AS, Henriquez D. 2006. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infection Control and Hospital Epidemiology 27:349-356. doi: 10.1086/503341
19. Munoz-Price LS, Weinstein RA. 2008. Acinetobacter infection. New England Journal of Medicine 358:1271-1281. doi: 10.1056/NEJMra070741
20. National Committee for Clinical Laboratory Standards. 2004. Performance Standards for Antimicrobial Disk Susceptibility Tests. NCCLS Document M100-514. Wayne Pa: National Committee for Clinical Laboratory Standards
21. Nguile-Makao M, Zahar JR, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S, Clec’h C, Souweine B, Timsit JF. 2010. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Medicine 36:781-789. doi: 10.1007/s00134-010-1824-6
22. Nhu NT, Lan NP, Campbell JI, Parry CM, Thompson C, Tuyen HT, Hoang NV, Tam PT, Le VM, Nga TV, Nhu TH, Van Minh P, Nga NT, Thuy CT, Dung le T, Yen NT, Van Hao N, Loan HT, Yen LM, Nghia HD, et al. 2014. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. Journal of Medical Microbiology 63:1386-1394. doi: 10.1099/jmm.0.076646-0
23. Opartkiattikul N, Bejrachandra S. 2002. The external quality assessment schemes in Thailand. Rinsho Byori. the Japanese Journal of Clinical Pathology 50:121-125.
24. Peleg AY, Hooper DC. 2010. Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine 362:1804-1813. doi: 10.1056/NEJMra0904124
25. Pumart P, Phodha T, Thamlikitkul V, Riewpaiboon A, Prakongsai P, Limwattananon S. 2012. Health and economic impacts of antimicrobial resistance in Thailand. Journal Health Services Research Policy 9:352-360
26. Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. 2009. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases 49: 1175-1184. doi: 10.1086/605630
27. Rosenthal VD, Guzman S, Orellano PW. 2003. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. American Journal of Infection Control 31:291-295. doi: 10.1067/mic.2003.1
28. Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH, Balkhy H, Hu B, Alvarez-Moreno C, Medeiros EA, Apisarnthanarak A, Raka L, Cuellar LE, Ahmed A, Navoa-Ng JA, El-Kholy AA, Kanj SS, Bat-Erdene I, Duszynska W, Van Truong N, et al. 2014. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. American Journal of Infection Control 42:942-956. doi: 10.1016/j.ajic.2014.05.029
29. World Health Organization. 2014. Antimicrobial resistance: global report on surveillance. (accessed December 9, 2015) http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1
30. World Bank. 2015. Thailand Overview. (accessed 12/09/2015) http://www.worldbank.org/en/country/thailand/overview